Title
Long-term effect of Bifidobacteria and Neosugar on precursor lesions of colonic cancer in CF1 mice.
Author
Koo M; Rao AV
Source
Nutr Cancer, 1991, 16:3-4, 249-57
Abstract
This investigation was undertaken to study the role of Bifidobacteria and bifidogenic factor Neosugar in the process of 1,2-dimethylhydrazine-induced colonic carcinogenesis in CF1 mice. Intestinal colonization and selective proliferation of Bifidobacteria were achieved by oral administration of indigenous Bifidobacteria and the incorporation of 5% Neosugar in the diet of animals. The Bifidobacteria were isolated from the feces of CF1 mice and were identified to be Bifidobacterium pseudolongum biovar b. This incidence of aberrant crypts and foci were significantly lower 38 weeks after the last injection of the carcinogen in animals fed Bifidobacteria than in animals treated with the carcinogen alone. The aberrance also appeared to be confined to the more distal end of the colon in animals fed bifidogenic diet. Such changes in the precursor lesions of colonic carcinogenesis are presumably due to the increase in the number of Bifidobacteria and their acidifying action in the lower intestinal tract of the animals.

Title
Survival of bifidobacteria ingested via fermented milk during their passage through the human small intestine: an in vivo study using intestinal perfusion.
Author
Pochart P; Marteau P; Bouhnik Y; Goderel I; Bourlioux P; Rambaud JC
Source
Am J Clin Nutr, 1992 Jan, 55:1, 78-80
Abstract
The ability of a strain of Bifidobacterium sp to survive passage through the upper gastrointestinal tract when ingested in fermented milk was investigated in six fasting healthy adults by using in vivo ileal perfusion. After ingestion of 10.0 +/- 0.5 log10 bifidobacteria in 400 g fermented milk, ileal flow of bifidobacteria increased significantly and reached a maximum of 8.8 +/- 0.2 log10 bifidobacteria/h 1.7 +/- 0.4 h after ingestion of fermented milk. The average number of bifidobacteria recovered from the terminal ileum during the 8 h after fermented-milk ingestion was 9.0 +/- 0.1 log10 and constituted 23.5 +/- 10.4% of the number ingested. These results indicate that in healthy adults Bifidobacterium sp survive transit through the gastrointestinal tract when ingested in fermented milk. Further studies are needed to investigate the behavior of these exogenous bacteria in the colonic lumen and to explore their effects on the physiology of the human gastrointestinal tract.

Title
Occurrence of bifidobacteria in the stool of multiple sclerosis patients.
Author
Wagenfeld K
Source
Zentralbl Bakteriol, 1991 Oct, 275:4, 541-8
Abstract
Stool specimens from 17 multiple sclerosis (MS) patients were examined for bifidobacteria. The count of colony forming units (CFU)/g faeces and the differentiation and typing of species, especially of Bifidobacterium adolescentis biotypes were performed. The pH of the samples was also measured. Stool specimens from 17 healthy volunteers were examined as a control by the same methods (a modified medium, suitable for the detection and recognition of bifidobacteria in adults is given). The results demonstrate a significant deficiency in bifidobacteria of the adolescentis group in MS patients. In 3 patients, no bifidobacteria could be detected (less than 10(7]. In comparison with the samples from healthy donors, B. adolescentis "c" was reduced and B. adolescentis "a" could not be detected at all in MS patients' stool specimens. The occurrence of B. adolescentis "b" and B. adolescentis "d" as well as the species B. bifidum and B. longum did not significantly differ within both groups. The pH was only slightly increased in the MS group.

Title
Phenotypic differentiation of bifidobacteria of human and animal origins.
Author
Gavini F; Pourcher AM; Neut C; Monget D; Romond C; Oger C; Izard D
Source
Int J Syst Bacteriol, 1991 Oct, 41:4, 548-57
Abstract
The phenotypes of 153 strains belonging or related to the genus Bifidobacterium were studied. These organisms included 38 collection strains and 115 wild strains (41 strains of human origin, 56 strains of animal origin, and 18 strains obtained from rivers or sewage). Our phenotypic analysis revealed seven main groups that were subdivided into 20 subgroups. Seven subgroups contained no type or collection strain. Among the human strains, the type strains of Bifidobacterium pseudocatenulatum and B. catenulatum fell into group I, which contained the type strains of B. adolescentis (subgroup Ib), B. dentium (subgroup Ic), and B. angulatum (ungrouped). The type strain of B. breve belonged to subgroup IIIa1, and the type strains of B. infantis and B. longum fell into subgroup IIIb1. Group VII comprised only wild strains that were isolated from human infant feces. Among the animal strains, group II consisted mainly of bifidobacteria that were isolated from pig feces and contained the type strains of B. suis (subgroup IIb), B. thermophilum (subgroup IIf), B. choerinum, and B. boum (ungrouped). Wild strains belonging to group V were isolated from pig, calf, cow, and chicken feces; this included the type strains of B. animalis (subgroup Va), B. magnum (subgroup Vb), B. pseudolongum, and B. globosum (subgroup Vc). The strains of human origin (groups I, III, and VII) were well separated from the animal strains (groups II, IV, and V). It was not surprising that the wild strains isolated from surface water or sewage were distributed in the animal groups as well as the human groups. Thus, bifidobacteria can be considered to be successful indicators of human or animal fecal pollution when they are correctly classified. The acidification patterns were not adequate to differentiate Bifidobacterium species, as determined previously by Mitsuoka (Bifidobacteria Microflora 3:11-28, 1984) and Scardovi (p. 1418-1434, in P. H. A. Sneath, N. S. Mair, M. E. Sharpe, and J. G. Holt, ed., Bergey's Manual of Systematic Bacteriology, vol. 2, 1986). However, enzymatic tests furnished new taxonomic criteria for the genus.

Title
Symbiotic interactions between colonic microflora and protein metabolism in infants.
Author
Heine W; Mohr C; Wutzke KD; Radke M Address Department of Paediatrics, University of Rostock, Germany.
Source
Acta Paediatr Scand, 1991 Jan, 80:1, 7-12
Abstract
The utilization of 15N nitrogen from 15N-labelled bifidobacteria for whole body protein synthesis was studied in 4 infants by oral single-pulse labellings and in 3 other infants, who had colostomies, by colonic pulse labellings. The bifidobacteria were harvested from a modified Petuely culture medium containing 15N ammonium chloride and 15N cystine as the only Sources of nitrogen. The tracer dose chosen for the balance studies was 3 mg 15N/kg. 15N concentrations in urine and feces collected over 48 hours after the pulse labellings were determined by emission spectrometry. Oral administration of 15N-labelled bifidobacteria resulted in absorption of approximately 90% renal excretion of 15%, and fecal excretion of 12% of the tracer dose, respectively. Retention in the protein pool averaged 73%. After colonic single pulse labelling with 15N-labelled bifidobacteria, the corresponding values were 85.5%, 2.2%, 14.5% and 83.0%, respectively. Absorption and incorporation of the heavy nitrogen into body proteins were directly demonstrated by increased 15N atom percent excess values within the trichloroacetic acid (TCA) supernatants and the proteins of the plasma, 0.25 and 0.04 atom%, respectively, at 24 hours after oral pulse labellings. One half of the total 15N excreted in urine consisted of urea and approximately 8% was eliminated as ammonia.

Title
Transient colonization of the gut of newborn infants by orally administered bifidobacteria and lactobacilli.
Author
Bennet R; Nord CE; Zetterström R
Source
Acta Paediatr, 1992 Oct, 81:10, 784-7
Abstract
We investigated if orally administered bifidobacteria and/or lactobacilli could be cultured from faeces of infants after antibiotic treatment, when these bacterial species are usually absent. Lyophilized Bifidobacterium longum, strain BB-536, B. breve, strain BB-576, or Lactobacillus acidophilus, strain LAC-343, were used. Doses of 3 x 10(9) cells of one strain, or a mixture of all three strains 3 x 10(9) cells each were fed three times daily at mealtimes to 11 infants aged 0-8 weeks. Treatment was started the first day after antibiotic treatment and was continued for 5 days. The bacterial species were isolated in 9 of 11, 7 of 10 and 2 of 9 specimens obtained on the last day of bifidobacteria or lactobacilli administration, 5 and 15 days thereafter, respectively. No side effects were noted.

Title
Survival of bifidobacteria from human habitat in acidified milk.
Author
Biavati B; Sozzi T; Mattarelli P; Trovatelli LD
Source
Microbiologica, 1992 Apr, 15:2, 197-200
Abstract
Some industrial preparations from milk, such as yogurt, contain bifidobacteria as an additional probiotic element. The acidic environment of these products affects the viability of the bifidobacteria. The survival in acidic environment of one-hundred and ten bifidobacterial strains from human habitat was tested.

Title
Fecal recovery in humans of viable Bifidobacterium sp ingested in fermented milk.
Author
Bouhnik Y; Pochart P; Marteau P; Arlet G; Goderel I; Rambaud JC
Source
Gastroenterology, 1992 Mar, 102:3, 875-8
Abstract
Bifidobacterium sp is a natural component of the dominant colonic microflora that was recently introduced into several fermented dairy products. The aim of the present study was to study the fate of this microorganism in the human gut. On the basis of antibiotic resistance characters, a variant of Bifidobacterium sp that could be distinguished from indigenous bifidobacteria in the fecal flora was selected, and its survival and colonization in the colon was examined. This strain was used to ferment milk, and 125 g of the fermented product obtained was ingested by eight healthy volunteers three times daily for 8 days. Stools were recovered and weighed throughout the study. The results showed that the exogenous Bifidobacterium sp appeared in the stools and reached a mean level of 8.8 +/- 0.1 log colony-forming units per gram. This level was maintained as long as the fermented dairy product was consumed. When its ingestion stopped, the exogenous Bifidobacterium sp gradually decreased and was no longer detectable 8 days after cessation. The mean recovered quantity during the 8-day period of administration of the ingested bifidobacteria excreted in stools was 12.1 +/- 0.1 log colony-forming units per gram, i.e., 29.7% +/- 6% of the ingested bacteria, which was similar to the percentage that reached the colon in previous studies. It is concluded that under physiological conditions, exogenously administered Bifidobacterium sp do not colonize the human colon. However, the high fecal concentrations of exogenous bifidobacteria reached are compatible with metabolic "probiotic" activities.

Title
Host-microflora correlations in infant nutrition.
Author
Heine W; Mohr C; Wutzke KD
Source
Prog Food Nutr Sci, 1992, 16:2, 181-97
Abstract
The intestinal microflora represents an enormous cell mass and has a high metabolic capacity. The symbiotic efficacy of these microbes in humans is still a matter of discussion. Of particular interest, from a biogenetic point of view, are potential symbiotic relations between the bifidobacterial microflora and the breast-fed infant. Our group has conducted studies related to this topic; they were aimed at determining the dimension of microbial assimilation by the host. Our studies with 15N-labeled bifidobacteria have shown that the bifidobacterial microflora is capable of upgrading nonessential nitrogen such as urea nitrogen for the synthesis of microbial protein. Oral single pulse labelings with 15N-labeled bifidobacteria were absorbed to approximately 90% and retained in the infant's protein pool to approximately 70%. These findings demonstrate the high intensity of the substrate flow from the microflora to the host. This might become important under conditions of marginal food protein intake or during periods of accelerated growth.

Title
Response of bifidobacterium species to growth promoters in human and cow milk.
Author
Petschow BW; Talbott RD
Source
Pediatr Res, 1991 Feb, 29:2, 208-13
Abstract
We used an in vitro assay to study and compare the growth-promotional activity of protein and nonprotein components in human milk (HM) and cow milk (CM) samples for infant strains of Bifidobacterium species. HM samples varied considerably in growth-promotion activity for Bifidobacterium bifidum var pennsylvanicus, Bifidobacterium infantis, and Bifidobacterium breve. Pooled CM samples showed similar but less variable levels of activity when compared with HM samples. Separation of milk samples by ultrafiltration into protein nitrogen and nonprotein nitrogen (NPN) fractions revealed that the bifidobacteria growth-promotion activity of HM was associated primarily with the NPN fraction, whereas activity in CM whey was found in both protein nitrogen and NPN fractions. Testing of purified CM whey proteins showed that alpha-lactalbumin and lactoferrin were potent growth promoters, showing greater activity for B. infantis and B. breve than for two strains of B. bifidum. Conversely, N-acetylglucosamine and purified gastric mucin were highly active for B. bifidum strains but inactive for other Bifidobacterium species. Collectively, the data indicate that both protein nitrogen and NPN factors in HM and CM promote the growth of bifidobacteria and suggest that Bifidobacterium species differ in responsiveness to protein and oligosaccharide growth promoters.